H-1B sponsorship profile: Nektar Therapeutics. Across U.S. Department of Labor LCA disclosures, Nektar Therapeutics filed 7 Labor Condition Applications covering 7 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (7 certified of 7 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Nektar Therapeutics’s H-1B petitions range from $104,000 at the low end to $178,214 at the high end, with a petition-weighted average of $145,372. That range reflects the mix of occupations the company sponsors, led by Sr. Clinical Data Management Specialist (2 petitions at $176,665 avg), followed by Principal Biostatistician and Staff Scientist, Process Development. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Nektar Therapeutics is headquartered in San Francisco, CA under NAICS code 325412, and places H-1B workers across 2 states, most heavily in CA, AL. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Nektar Therapeutics ranks. By H-1B petition volume, Nektar Therapeutics is #21,197 of 119,880 employers nationally and #3,483 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.